Helicobacter Pylori: smontiamo le bugie
Dottor Gabriele Prinzi

Credit immagine Vitamineral

 

Da un articolo del Dr Gabriele Prinzi

Non di solo antibiotico muore l’Helicobacter: smontiamo le bugie.

In tutto il mondo, l’Helicobacter pylori (HP) è considerato il principale agente eziologico dell’ulcera peptica e del carcinoma gastrico.
Si suppone che circa il 50% della popolazione mondiale ne è infetto.

Ma solo in una piccola percentuale di casi (10%) parliamo dell’HP “cattivo”.

Sono stati riportati numerosi studi farmacologici per l’eradicazione dell’HP tra cui inibitori della pompa protonica (IPP) antibiotici, sali di bismuto, anti-H2 (farmaci antiacidi come ranitidina, cimetidina e famotidina).

Tutti protocolli, tutte “terapie standard”.
Ma le terapie per l’eradicazione sembrano aver fallito a causa di molte ragioni.
Tra cui la resistenza acquisita contro gli antibiotici.

Ma andiamo per gradi.

La terapia farmacologica infatti si basa su ALMENO DUE ANTIBIOTICI combinati con una doppia dose di inibitore della pompa protonica (IPP).
Il problema principale della terapia di eradicazione è la resistenza crescente di HP agli antibiotici più comunemente usati.

Di conseguenza, alcuni pazienti sottoposti a molti di queste “terapie standard” presentano un fallimento terapeutico.

Inoltre, queste terapie includono l’assunzione di troppi farmaci che potrebbero causare effetti collaterali che – insieme a costi significativi per il trattamento – che principalmente sono gastrointestinali (diarrea, nausea e disturbi del gusto) e spesso portano alla sospensione del trattamento.
...Perché quando si è piegati in due dal dolore, pure un Santo interromperebbe il trattamento…

A peggiorare la cosa, nessun MEDICO ONESTO potrà mai dire che quei DUE (ALMENO) ANTIBIOTICI sono ultra-selettivi per HP e che agiscono solo sull’HP.
Quindi, è CERTIFICATO SCIENTIFICAMENTE che il trattamento antibiotico HP a lungo termine determina una modifica qualitativa e quantitativa della flora intestinale (disbiosi) e determina la selezione di ceppi antibiotico-resistenti di HP e di altri batteri intestinali.

In più, non c’è antibiotico che non “migliori la colonizzazione del tratto gastrointestinale” da parte dei funghi (Candida) e che non possa portare a una grave infezione da Clostridium difficile.

Chi questo lo nega TI STA MENTENDO.

Giacché SIBO e SIFO (rispettivamente sovracrescita batterica e fungina del piccolo intestino) sono effetti collaterali NOTI E PREVEDIBILI dell’assunzione del “castroprotettore” (IPP).

Adesso… ad essere totalmente onesti… l’HP accompagna l’uomo da almeno 58.000 anni, se non 100.000.
Sempre più dati indicano che la colonizzazione batterica da HP (nonché le conseguenze negative a lungo termine) possono anche aver fornito alcuni benefici all’ospite.
QUALI BENEFICI TI CHIEDERAI?

… Visto che nessuno te lo ha mai detto, permettimi di rivelarti un segreto…

È noto che l’infezione da HP mitiga il decorso dell’infezione con altri patogeni intestinali più virulenti (ad es. Vibrio cholerae) e può proteggere dalle infezioni gastrointestinali diarroiche nei bambini.

Studi scientifici sulla popolazione infetta da HP mostrano riduzione della prevalenza dell’asma atopica e altre malattie atopiche (come la dermatite).
Nonché la riduzione della celiachia, della sindrome dell’intestino irritabile (IBS), nella malattia da reflusso gastroesofageo e nella frequenza dell’adenocarcinoma esofageo.

Detto in poche parole: l’Helicobacter Pylori ci protegge da tante malattie…
E ci dovremmo domandare se l’aumento delle allergie dei nostri figli, o della celiachia e della gluten sensitivity non sia dovuto alla scomparsa dell’HP dalle madri – giacché PER ANNI abbiamo sparato, forse, al soggetto sbagliato e forse usando bombe TROPPO atomiche.
Senza misurare gli effetti a medio lungo termine.
Che oggi abbiamo misurato.
Anzi, sono notizie che sappiamo dal 1995…
Comunque, alla ricerca di nuove terapie anti- HP abbiamo guardato al passato, nel campo delle piante terapeutiche.

Fitoterapici per la cura della Sovracrescita dell’Helicobacter Pylori

Numerosi studi sono stati condotti su un gran numero di varietà vegetali, che esibiscono le proprie azioni anti-HP attraverso diversi meccanismi: effetti antisecretori o curativi, antiossidanti e antinfiammatori.
Le piante con attività anti-HP (sono numerose!) sono composte da vari fitocomposti, come alcaloidi, flavonoidi, saponine, terpeni e polisaccaridi, responsabili dell’attività antimicrobica.
Un esempio?
Gli estratti di Borragine, Prezzemolo e Curcuma, e l’estratto acquoso di radice di Liquirizia, sono in grado di ridurre l’adesione di HP alla mucosa gastrica.
L’ inibizione di HP con terapie antibiotiche ha una limitazione principalmente a causa della resistenza agli antibiotici.
E agli effetti collaterali

Le erbe medicinali offrono un’altra opportunità per inibire l’HP.
E alcune potrebbero anche fornire un approccio efficace per ridurre il rischio di cancro allo stomaco.
Ma fintanto che CREDI ALLE BUGIE CHE TI DICONO e ascolti il DOGMA per cui l’unico HP buono è quello morto… e ti fai riempire di ANTIBIOTICI INUTILMENTE … gli effetti collaterali sono certi e non belli.

Perché sono uno che crede che DEVI SAPERE LA VERITÀ e avere le informazioni giuste per poter fare una SCELTA.
Perché la tua salute vale!

LINK AL LAVORO ORIGINALE:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248673/


Il lavoro preso in esame dal dottor Prinzi considera oltre 200 lavori su Erbe Mediche da tutte le parti del mondo e culture diverse e tutte in relazione allo stomaco con un problema dall’Helicobacter Pylori.
Eppure la medicna Classica Ortodossa del farmaco come unica cura continua ad usare gli antibiotici con le conseguenze che sappiamo.

Allego parte della traduzione coi referimenti

 Meccanismi di piante medicinali come anti-H.pylori

Molti prodotti naturali hanno potenziali anti-H. pylori. I meccanismi di tali potenziali includono l’inibizione dell’ureasi, il danno al DNA, l’inibizione della sintesi proteica e gli effetti antinfiammatori. Oltre agli effetti anti-H. pylori dovuti ad alcuni enzimi come la diidrofolato reduttasi e la mieloperossidasi N- acetiltransferasi.

Inibizione dell’urea

Il potente effetto del resveratrolo come anti- H. pylori è dovuto principalmente all’inibizione dell’ureasi [  ]. L’azione anti- H. pylori delle radici di Paeonia lactiflora è dovuta all’idrofobicità del 1,2,3,4,6-penta- O -galloil-β- d- glucopiranosio che facilita il legame alle membrane portando alla perdita dell’integrità della membrana così come l’inibizione dell’ureasi [  ]. È stato riportato che sia la frazione CHCl 3 che l’estratto EtOH della corteccia del gambo di Calophyllum brasiliense riducono l’ attività dell’H. Pylori e dell’ureasi nei ratti Wistar, come confermato dall’istopatologia [ ]. Il meccanismo d’azione dell’estratto acquoso di mirtillo rosso e origano può essere dovuto all’inibizione della prolina deidrogenasi e dell’attività dell’ureasi [  ]. Sia gli estratti di Calotropis procera che di Acacia nilotica inibiscono l’attività dell’ureasi attraverso meccanismi competitivi [  ].

Lo stress ossidativo

Il 2-metossi-1,4-naftochinone mostra una forte azione anti H. pylori . Il 2-metossi-1,4-naftochinone è metabolizzato nella membrana di H. pylori dai flavoenzimi e produce un’elevata quantità di radicali liberi che possono danneggiare le macromolecole cellulari e portare alla morte di H. pylori [  ].

Attività antiaderente

Si è scoperto che gli estratti di acqua di borragine, prezzemolo e curcuma sono in grado di diminuire l’adesione di H. pylori [  ]. L’estratto acquoso di Liquoriceroot e i polisaccaridi mostrano una forte attività antiadesiva delle aliquote di mucosa gastrica umana con H. pylori marcato con fluorescenza [  ]. L’ estratto di radice di Pelargonium sidoides mostra attività antiadesiva [  ]. Si trova anche che il diterpene Plaunotol, isolato dalle foglie di plau-noi, inibisce l’adesione di H. pylori così come l’inibizione della secrezione di IL-8 [  ]

Relazione attività struttura

Le piante con attività anti H. Pylori sono costituite da vari fitocomposti, come alcaloidi, flavonoidi, saponine, terpeni e polisaccaridi, responsabili dell’attività antimicrobica (Fig. 2) sono discussi all’interno di questa recensione in Tavolo 2.

Elenco di alcune delle piante per la riduzione delle ulcere da HP, gastroprotezione, effetti antinfiammatori ed antiossidanti.

Resveratrolo, Mirtillo rosso, Melatonina, Mentolo, Quercetina, Aglio arricchito di Slenio, Aglio e Vitamina E, estratti di Cannella, Achillea millefolium, Acacia nilotica, Ageratina pichinchensis, Ageratum conyzoides, Agrimonia pilosa Ledeb, Allium sativum, Allium ascalonicum Linn. pianta intera, Alchornea triplinervia , Ippocastano dal quale si estrae l’escina, foglie di mora ( Rubus ulmifolius ), corteccia della radice di Aralia elata, Anthemis altissima, Anisomeles indica, Arrabidaea chica, Atractylodes ovata,

Olio essenziale di Baccharis dracunculifolia DC, Boesenbergia rotunda (L.), acido boropinico, Cochlospermum tinctorium, Chamomilla recutita, foglie di Cistus laurifolius, Citrus Lemon (Rutaceae), Citrus aurantium, Cocculus hirsutus, Croton reflexifolius,  diterpene Plaunotol isolato dalle foglie di plau-noi, estratto EtOH della corteccia del gambo di Calophyllum, Casearia sylvestris, Cyrtocarpa procera Kunth (Anacardiaceae),

Garcinia kola seed., Garcinia achachairu Rusby (Clusiaceae), Geranium wilfordii, Geum iranicum, Germogli di broccoli, Green tea extract in Mongolian gerbils, Amphipterygium adstringens, corteccia di Bridelia micrantha, corteccia di gambo di Khaya senegalensis A, Davilla elliptica e Davilla nitida, Desmostachya bipinnata, Dittrichia viscosa, Eucalyptus camaldulensis, Eucalyptus torelliana, Eucalyptus globulus, Eupatorium aschenbornianum, frutti di Feijoa sellowiana, radici di Ferulago campestris (Apiaceae),

Hancornia speciosa, Fungo Lion’s Mane, Hericium erinaceus (Basidiomiceti superiori), Sanguinaria canadensis e Hydrastis canadensis,  Hyptis suaveolens, Ixeris chinensis, Larrea divaricata Cav (jarilla), foglie di Mangifera indica L., Mastice di Chios, Morus alba, Musa sapientum, Myroxylon peruiferum, Myrtus communis , estratto di foglie di Olea europaea, Ocimum sanctum (Holy Basil),

Paeonia lactiflora Pelargonium sidoides, gambo di Calophyllum brasiliense, estratti di Calotropis procera, Cichorium intybus, corteccia delle radici di Hippocratea excelsa (Hippocrataceae), Pistacia terebinthus galls, Glycyrrhiza glabra L, Impatiens balsamina L, Satureja hortensis L., Alchornea triplinervia, blackberry leaves (Rubus ulmifolius),

Simaba ferruginea, Senecio brasiliensis, Pausinystalia yohimbe, Physalis peruviana calyces, propoli brasiliana, Syngonanthus bisulcatus (Eriocaulaceae), indigo plant (Polygonum tinctorium Lour.), Panax ginseng, Peperomia pellucida, Chancapiedra Phyllanthus niruri L., Physalis alkekengi L., Piper carpunya, Piper multiplinervium, Plectranthus grandis, Plumbago zeylanica L., Polygala cyparissias, Potentilla, Psoralea corylifolia, Pteleopsis suberosa, Punica granatum pericarps,


Quercus infectoria, Qualea parviflora, Rabdosia trichocarpa, Rubus imperialis, Rutina, Sclerocarya birrea (Anacardiaceae), Solanum paniculatum , Lamiaceae Sphacele chamaedryoides (Balbis), Strychnos pseudoquina St. Hil. (Loganiaceae), Syzygiumaromaticum ,

Oroxylum indicum, Tabebuia impetiginosa, Termitomyces eurhizus, Terminalia chebula Retz, polvere di Shoya, oli essenziali di Thymus vulgaris, Tithonia diversifolia,  Uncaria rhynchophylla, ginger Zingiber officinale.

 


References

  1. 1. Lawal T.O., Igbokwe C.O., Adeniyi B.A. Antimicrobial activities and the bactericidal kinetics of Allium ascalonicum Linn. whole plant) against standard and clinical strains of Helicobacter pylori: support for ethnomedical use. J. Nat. Sci. Res. 2014;4(8):48–56. []
  2. 2. Conteduca V., Sansonno D., Lauletta G., Russi S., Ingravallo G., Dammacco F. H. pylori infection and gastric cancer: state of the art. Int. J. Oncol. 2013;42(1):5–18. doi: 10.3892/ijo.2012.1701. [PubMed] [CrossRef] []
  3. 3. Wolle K., Malfertheiner P. Treatment of Helicobacter pylori. Best Pract. Res. Clin. Gastroenterol. 2007;21(2):315–324. doi: 10.1016/j.bpg.2006.11.001. [PubMed] [CrossRef] []
  4. 4. Paulo L., Oleastro M., Gallardo E., Queiroz J.A., Domingues F. Anti-Helicobacter pylori and urease inhibitory activities of resveratrol and red wine. Food Res. Int. 2011;44(4):964–969. doi: 10.1016/j.foodres.2011.02.017. [CrossRef] []
  5. 5. Ngan L.T.M., Moon J.K., Shibamoto T., Ahn Y.J. Growth-inhibiting, bactericidal, and urease inhibitory effects of Paeonia lactiflora root constituents and related compounds on antibiotic-susceptible and-resistant strains of Helicobacter pylori. J. Agric. Food Chem. 2012;60(36):9062–9073. doi: 10.1021/jf3035034. [PubMed] [CrossRef] []
  6. 6. do Carmo Souza M., Beserra A.M.S., Martins D.C., Real V.V., dos Santos R.A.N., Rao V.S., da Silva R.M., de Oliveira Martins D.T. In vitro and in vivo anti-Helicobacter pylori activity of Calophyllum brasiliense Camb. J. Ethnopharmacol. 2009;123(3):452–458. doi: 10.1016/j.jep.2009.03.030. [PubMed] [CrossRef] []
  7. 7. Lin Y.T., Kwon Y.I., Labbe R.G., Shetty K. Inhibition of Helicobacter pylori and associated urease by oregano and cranberry phytochemical synergies. Appl. Environ. Microbiol. 2005;71(12):8558–8564. doi: 10.1128/AEM.71.12.8558-8564.2005. [PMC free article] [PubMed] [CrossRef] []
  8. 8. Amin M., Anwar F., Naz F., Mehmood T., Saari N. Anti-Helicobacter pylori and urease inhibition activities of some traditional medicinal plants. Molecules. 2013;18(2):2135–2149. doi: 10.3390/molecules18022135. [PMC free article] [PubMed] [CrossRef] []
  9. 9. Wang Y.C., Li W.Y., Wu D.C., Wang J.J., Wu C.H., Liao J.J., Lin C.K. In vitro activity of 2-methoxy-1, 4-naphthoquinone and stigmasta-7, 22-diene-3β-ol from Impatiens balsamina L. against multiple antibiotic-resistant Helicobacter pylori. Evid. Based Complement. Altern. Med. 2011;2011 doi: 10.1093/ecam/nep147. [PMC free article] [PubMed] [CrossRef] []
  10. 10. O’Mahony R., Al-Khtheeri H., Weerasekera D., Fernando N., Vaira D., Holton J., Basset C. Bactericidal and anti-adhesive properties of culinary and medicinal plants against Helicobacter pylori. World J. Gastroenterol. 2005;11(47):7499. doi: 10.3748/wjg.v11.i47.7499. [PMC free article] [PubMed] [CrossRef] []
  11. 11. Wittschier N., Faller G., Hensel A. Aqueous extracts and polysaccharides from liquorice roots (Glycyrrhiza glabra L.) inhibit adhesion of Helicobacter pylori to human gastric mucosa. J. Ethnopharmacol. 2009;125(2):218–223. doi: 10.1016/j.jep.2009.07.009. [PubMed] [CrossRef] []
  12. 12. Wittschier N., Faller G., Hensel A. An extract of Pelargonium sidoides (EPs 7630) inhibits in situ adhesion of Helicobacter pylori to human stomach. Phytomedicine. 2007;14(4):285–288. doi: 10.1016/j.phymed.2006.12.008. [PubMed] [CrossRef] []
  13. 13. Takagi A., Koga Y., Aiba Y., Kabir A.M., Watanabe S., Ohta‐Tada U., Osaki T., Kamiya S., Miwa T. Plaunotol suppresses interleukin‐8 secretion induced by Helicobacter pylori: therapeutic effect of plaunotol on H. pylori infection. J. Gastroenterol. Hepatol. 2000;15(4):374–380. doi: 10.1046/j.1440-1746.2000.02168.x. [PubMed] [CrossRef] []
  14. 14. Giner-Larza E.M., Máñez S., Giner R.M., Recio M.C., Prieto J.M., Cerdá-Nicolás M., Ríos J. Anti-inflammatory triterpenes from Pistacia terebinthus galls. Planta Med. 2002;68(04):311–315. doi: 10.1055/s-2002-26749. [PubMed] [CrossRef] []
  15. 15. Navarrete A., Trejo-Miranda J.L., Reyes-Trejo L. Principles of root bark of Hippocratea excelsa (Hippocrataceae) with gastroprotective activity. J. Ethnopharmacol. 2002;79(3):383–388. doi: 10.1016/S0378-8741(01)00414-7. [PubMed] [CrossRef] []
  16. 16. El-Gengaihi S.E., Hamed M.A., Aboubaker D.H., Mossa A.T. Flavonoids from sugar beet leaves as hepatoprotective agent. Int. J. Pharm. Pharm. Sci. 2016;8:281–286. []
  17. 17. El-Gengaihi S.E., Mossa A.T.H., Refaie A.A., Aboubaker D. Hepatoprotective efficacy of Cichorium intybus L. extract against carbon tetrachloride-induced liver damage in rats. J. Diet. Suppl. 2016;13:570–584. doi: 10.3109/19390211.2016.1144230. [PubMed] [CrossRef] []
  18. 18. Baker D.A., Al-Moghazy M., ElSayed A.A.A. The in vitro cytotoxicity, antioxidant and antibacterial potential of Satureja hortensis L. essential oil cultivated in Egypt. Bioorg. Chem. 2020;95:103559. https://www.researchgate.net/publication/301490287 [PubMed] []
  19. 19. Abou Baker D.H., Rady Hanaa M. Bioassay-guided approach employed to isolate and identify anticancer compounds from Physalis peruviana calyces. Plant Arch. 2020;20(1):3285–3291. https://www.researchgate.net/publication/340132967 []
  20. 20. Abou Baker D.H. Achillea millefolium L. ethyl acetate fraction induces apoptosis and cell cycle arrest in human cervical cancer (HeLa) cells. Ann. Agric. Sci. 2020 doi: 10.1016/j.aoas.2020.03.003. In press. [CrossRef] []
  21. 21. Salam M.A., Ibrahim B.M., El-Batran S.E., El-Gengaihi S.E., Baker D.H. Study of the possible antihypertensive and hypolipidemic effects of an herbal mixture on l-name-induced hypertensive rats. Asian J. Pharm. Clin. Res. 2016;9:85–90. doi: 10.22159/ajpcr.2016.v9i5.12175. [CrossRef] []
  22. 22. Coelho R.G., Batista L.M., Santos L.C.D., Brito A.R.M.D.S., Vilegas W. Phytochemical study and antiulcerogenic activity of Syngonanthus bisulcatus (Eriocaulaceae) Rev. Bras. Cinêc. Farm. 2006;42(3):413–417. doi: 10.1590/S1516-93322006000300010. [CrossRef] []
  23. 23. Olaleye S.B., Farombi E.O. Attenuation of indomethacin‐and HCl/ethanol‐induced oxidative gastric mucosa damage in rats by kolaviron, a natural biflavonoid of Garcinia kola seed. Phytother. Res. 2006;20(1):14–20. doi: 10.1002/ptr.1793. [PubMed] [CrossRef] []
  24. 24. González-Segovia R., Quintanar J.L., Salinas E., Ceballos-Salazar R., Aviles-Jiménez F., Torres-López J. Effect of the flavonoid quercetin on inflammation and lipid peroxidation induced by Helicobacter pylori in gastric mucosa of guinea pig. J. Gastroenterol. 2008;43(6):441. doi: 10.1007/s00535-008-2184-7. [PubMed] [CrossRef] []
  25. 25. Kataoka M., Hirata K., Kunikata T., Ushio S., Iwaki K., Ohashi K., Ikeda M., Kurimoto M. Antibacterial action of tryptanthrin and kaempferol, isolated from the indigo plant (Polygonum tinctorium Lour.), against Helicobacter pylori-infected Mongolian gerbils. J. Gastroenterol. 2001;36(1):5–9. doi: 10.1007/s005350170147. [PubMed] [CrossRef] []
  26. 26. Martini S., D’Addario C., Colacevich A., Focardi S., Borghini F., Santucci A., Figura N., Rossi C. Antimicrobial activity against Helicobacter pylori strains and antioxidant properties of blackberry leaves (Rubus ulmifolius) and isolated compounds. Int. J. Antimicrob. Agents. 2009;34(1):50–59. doi: 10.1016/j.ijantimicag.2009.01.010. [PubMed] [CrossRef] []
  27. 27. Matsubara S., Shibata H., Ishikawa F., Yokokura T., Takahashi M., Sugimura T., Wakabayashi K. Suppression of Helicobacter pylori-induced gastritis by green tea extract in Mongolian gerbils. Biochem. Biophys. Res. Commun. 2003;310(3):715–719. doi: 10.1016/j.bbrc.2003.09.066. [PubMed] [CrossRef] []
  28. 28. Kuo C.H., Weng B.C., Wu C.C., Yang S.F., Wu D.C., Wang Y.C. Apigenin has anti-atrophic gastritis and anti-gastric cancer progression effects in Helicobacter pylori-infected Mongolian gerbils. J. Ethnopharmacol. 2014;151(3):1031–1039. doi: 10.1016/j.jep.2013.11.040. [PubMed] [CrossRef] []
  29. 29. Asha M.K., Debraj D., Edwin J.R., Srikanth H.S., Muruganantham N., Dethe S.M., Anirban B., Jaya B., Deepak M., Agarwal A. In vitro anti-Helicobacter pylori activity of a flavonoid rich extract of Glycyrrhiza glabra and its probable mechanisms of action. J. Ethnopharmacol. 2013;145(2):581–586. doi: 10.1016/j.jep.2012.11.033. [PubMed] [CrossRef] []
  30. 30. Wang H.H., Chung J.G. Emodin-induced inhibition of growth and DNA damage in the Helicobacter pylori. Curr. Microbiol. 1997;35(5):262–266. doi: 10.1007/s002849900250. [PubMed] [CrossRef] []
  31. 31. Marhuenda E., Martin M.J., Alarcon Lastra C.D.L. Antiulcerogenic activity of aescine in different experimental models. Phytother. Res. 1993;7(1):13–16. doi: 10.1002/ptr.2650070105. [CrossRef] []
  32. 32. Jeong C.S., Hyun J.E., Kim Y.S., Lee E.S. Ginsenoside RB 1 the anti-ulcer constituent from the head of Panax ginseng. Arch. Pharm. Res. 2003;26(11):906. doi: 10.1007/BF02980198. [PubMed] [CrossRef] []
  33. 33. Lee E.B., Kim O.J., Kang S.S., Jeong C. Araloside A, an antiulcer constituent from the root bark of Aralia elata. Biol. Pharm. Bull. 2005;28(3):523–526. doi: 10.1248/bpb.28.523. [PubMed] [CrossRef] []
  34. 34. Klopell F.C., Lemos M., Sousa J.P.B., Comunello E., Maistro E.L., Bastos J.K., De Andrade S.F. Nerolidol, an antiulcer constituent from the essential oil of Baccharis dracunculifolia DC (Asteraceae) Z. Naturforschung C. 2007;62(7–8):537–542. doi: 10.1515/znc-2007-7-812. [PubMed] [CrossRef] []
  35. 35. Ohta Y., Kamiya Y., Imai Y., Arisawa T., Nakano H. Plaunotol prevents the progression of acute gastric mucosal lesions induced by compound 48/80, a mast cell degranulator, in rats. Pharmacology. 2005;74(4):182–192. doi: 10.1159/000085388. [PubMed] [CrossRef] []
  36. 36. Kim J.H., Kim Y.S., Song G.G., Park J.J., Chang H.I. Ulcers and gastrointestinal health. Eur. J. Pharmacol. 2005;514(1):53–59. [PubMed] []
  37. 37. Rodríguez J.A., Theoduloz C., Yáñez T., Becerra J., Schmeda-Hirschmann G. Gastroprotective and ulcer healing effect of ferruginol in mice and rats: assessment of its mechanism of action using in vitro models. Life Sci. 2006;78(21):2503–2509. doi: 10.1016/j.lfs.2005.10.018. [PubMed] [CrossRef] []
  38. 38. Rozza A.L., Hiruma-Lima C.A., Takahira R.K., Padovani C.R., Pellizzon C.H. Effect of menthol in experimentally induced ulcers: pathways of gastroprotection. Chem. Biol. Interact. 2013;206(2):272–278. doi: 10.1016/j.cbi.2013.10.003. [PubMed] [CrossRef] []
  39. 39. Rozza A.L., de Faria F.M., Brito A.R.S., Pellizzon C.H. The gastroprotective effect of menthol: involvement of anti-apoptotic, antioxidant and anti-inflammatory activities. PLoS One. 2014;9(1):e86686. doi: 10.1371/journal.pone.0086686. [PMC free article] [PubMed] [CrossRef] []
  40. 40. Nergard C.S., Diallo D., Inngjerdingen K., Michaelsen T.E., Matsumoto T., Kiyohara H., Yamada H., Paulsen B.S. Medicinal use of Cochlospermum tinctorium in Mali: anti-ulcer-, radical scavenging-and immunomodulating activities of polymers in the aqueous extract of the roots. J. Ethnopharmacol. 2005;96(1–2):255–269. doi: 10.1016/j.jep.2004.09.018. [PubMed] [CrossRef] []
  41. 41. Almeida E.S.S., Filho V.C., Niero R., Clasen B.K., Balogun S.O., Oliveira Martins D.T. Pharmacological mechanisms underlying the anti-ulcer activity of methanol extract and canthin-6-one of Simaba ferruginea A. St-Hil. in animal models. J. Ethnopharmacol. 2011;134:630–636. doi: 10.1016/j.jep.2011.01.009. [PubMed] [CrossRef] []
  42. 42. Toma W., Trigo J.R., Bensuaski de Paula A.C., Souza Brito. ARM Preventive activity of pyrrolizidine alkaloids from Senecio brasiliensis (Asteraceae) on gastric and duodenal induced ulcer on mice and rats. J. Ethnopharmacol. 2004;95:345–351. doi: 10.1016/j.jep.2004.08.017. [PubMed] [CrossRef] []
  43. 43. Konturek P.C., Konturek S.J., Majka J., Zembala M., Hahn E.G. Melatonin affords protection against gastric lesions induced by ischemia-reperfusion possibly due to its antioxidant and mucosal microcirculatory effects. Eur. J. Pharmacol. 1997;322(1):73–77. doi: 10.1016/S0014-2999(97)00051-4. [PubMed] [CrossRef] []
  44. 44. Ozaki Y. Pharmacological studies of indole alkaloids obtained from domestic plants, Uncaria rhynchophylla Miq. and Amsonia elliptica Roem. Et Schult. Nihon yakurigaku zasshi. Folia Pharmacol. Jpn. 1989;94(1):17–26. doi: 10.1254/fpj.94.17. [PubMed] [CrossRef] []
  45. 45. Mahady G.B., Pendland S.L., Stoia A., Hamill F.A., Fabricant D., Dietz B.M., Chadwick L.R. In vitro susceptibility of Helicobacter pylori to botanical extracts used traditionally for the treatment of gastrointestinal disorders. Phytother. Res. 2005;19(11):988–991. doi: 10.1002/ptr.1776. [PubMed] [CrossRef] []
  46. 46. Zaidi S.F., Muhammad J.S., Shahryar S., Usmanghani K., Gilani A.H., Jafri W., Sugiyama T. Anti-inflammatory and cytoprotective effects of selected Pakistani medicinal plants in Helicobacter pylori-infected gastric epithelial cells. J. Ethnopharmacol. 2012;141(1):403–410. doi: 10.1016/j.jep.2012.03.001. [PubMed] [CrossRef] []
  47. 47. Sánchez-Mendoza M.E., Rodríguez-Silverio J., Rivero-Cruz J.F., Rocha-González H.I., Pineda-Farías J.B., Arrieta J. Antinociceptive effect and gastroprotective mechanisms of 3, 5-diprenyl-4-hydroxyacetophenone from Ageratina pichinchensis. Fitoterapia. 2013;87:11–19. doi: 10.1016/j.fitote.2013.03.015. [PubMed] [CrossRef] []
  48. 48. Ndip R.N., Tarkang A.E.M., Mbullah S.M., Luma H.N., Malongue A., Ndip L.M., Nyongbela K., Wirmum C., Efange S.M. In vitro anti-Helicobacter pylori activity of extracts of selected medicinal plants from North West Cameroon. J. Ethnopharmacol. 2007;114(3):452–457. doi: 10.1016/j.jep.2007.08.037. [PubMed] [CrossRef] []
  49. 49. Li H., Meng L., Liu F., Wei J.F., Wang Y.Q. H+/K+-ATPase inhibitors: a patent review. Expert Opin. Ther. Pat. 2013;23(1):99–111. doi: 10.1517/13543776.2013.741121. [PubMed] [CrossRef] []
  50. 50. Lima Z.P., Calvo T.R., Silva E.F., Pellizzon C.H., Vilegas W., Brito A.R.M.S., Bauab T.M., Hiruma-Lima C.A. Brazilian medicinal plant acts on prostaglandin level and Helicobacter pylori. J. Med. Food. 2008;11(4):701–708. doi: 10.1089/jmf.2007.0676. [PubMed] [CrossRef] []
  51. 51. Lima Z.P., Bonamin F., Calvo T.R., Vilegas W., Santos L.C., Rozza A.L., Pellizzon C.H., Rocha L.R., Hiruma-Lima C.A. Effects of the ethyl acetate fraction of Alchornea triplinervia on healing gastric ulcer in rats. Pharmaceuticals. 2011;4(11):1423–1433. doi: 10.3390/ph4111423. [PMC free article] [PubMed] [CrossRef] []
  52. 52. O’Gara E.A., Hill D.J., Maslin D.J. Activities of garlic oil, garlic powder, and their diallyl constituents against Helicobacter pylori. Appl. Environ. Microbiol. 2000;66(5):2269–2273. doi: 10.1128/AEM.66.5.2269-2273.2000. [PMC free article] [PubMed] [CrossRef] []
  53. 53. Gail M.H., Pfeiffer R.M., Brown L.M., Zhang L., Ma J.L., Pan K.F., Liu W.D., You W.C. Garlic, vitamin, and antibiotic treatment for Helicobacter pylori: a randomized factorial controlled trial. Helicobacter. 2007;12(5):575–578. doi: 10.1111/j.1523-5378.2007.00528.x. [PubMed] [CrossRef] []
  54. 54. Gu L.K., Zhou P., Zhou J., Wang R.M., Yang W.J., Deng D.J. Effect of selenium-enriched garlic on chronic gastritis of the glandular stomach of Mongolian gerbils induced by H. pylori. Zhonghua Yu Fang Yi Xue Za Zhi. 2007;41:104–107. [PubMed] []
  55. 55. Liu S., Sun Y., Li W., Yu H., Li X., Liu Z., Zeng J., Zhou Y., Chen C., Jia J. The antibacterial mode of action of allitridi for its potential use as a therapeutic agent against Helicobacter pylori infection. FEMS Microbiol. Lett. 2010;303(2):183–189. doi: 10.1111/j.1574-6968.2009.01877.x. [PubMed] [CrossRef] []
  56. 56. Cellini L., Di Campli E., Masulli M., Di Bartolomeo S., Allocati N. Inhibition of Helicobacter pylori by garlic extract (Allium sativum) FEMS Immunol. Med. Microbiol. 1996;13(4):273–277. doi: 10.1111/j.1574-695X.1996.tb00251.x. [PubMed] [CrossRef] []
  57. 57. Prabjone R., Thong-Ngam D., Wisedopas N., Chatsuwan T., Patumraj S. Anti-inflammatory effects of Aloe vera on leukocyte–endothelium interaction in the gastric microcirculation of Helicobacter pylori-infected rats. Clin. Hemorheol. Microcirc. 2006;35(3):359–366. [PubMed] []
  58. 58. Hsieh S.C., Fang S.H., Rao Y.K., Tzeng Y.M. Inhibition of pro-inflammatory mediators and tumor cell proliferation by Anisomeles indica extracts. J. Ethnopharmacol. 2008;118(1):65–70. doi: 10.1016/j.jep.2008.03.003. [PubMed] [CrossRef] []
  59. 59. Rosas-Acevedo H., Terrazas T., González-Trujano M.E., Guzmán Y., Soto-Hernández M. Anti-ulcer activity of Cyrtocarpa procera analogous to that of Amphipterygium adstringens, both assayed on the experimental gastric injury in rats. J. Ethnopharmacol. 2011;134(1):67–73. doi: 10.1016/j.jep.2010.11.057. [PubMed] [CrossRef] []
  60. 60. Cho C.H., Mei Q.B., Shang P., Lee S.S., So H.L., Guo X., Li Y. Study of the gastrointestinal protective effects of polysaccharides from Angelica sinensis in rats. Planta Med. 2000;66(04):348–351. doi: 10.1055/s-2000-8552. [PubMed] [CrossRef] []
  61. 61. Castillo-Juárez I., González V., Jaime-Aguilar H., Martínez G., Linares E., Bye R., Romero I. Anti-Helicobacter pylori activity of plants used in Mexican traditional medicine for gastrointestinal disorders. J. Ethnopharmacol. 2009;122(2):402–405. doi: 10.1016/j.jep.2008.12.021. [PubMed] [CrossRef] []
  62. 62. Konstantinopoulou M., Karioti A., Skaltsas S., Skaltsa H. Sesquiterpene lactones from Anthemis altissima and their anti-Helicobacter pylori activity. J. Nat. Prod. 2003;66(5):699–702. doi: 10.1021/np020472m. [PubMed] [CrossRef] []
  63. 63. Mafioleti L., da Silva Junior I.F., Colodel E.M., Flach A., de Oliveira Martins D.T. Evaluation of the toxicity and antimicrobial activity of hydroethanolic extract of Arrabidaea chica (Humb. & Bonpl.) B. Verl. J. Ethnopharmacol. 2013;150(2):576–582. doi: 10.1016/j.jep.2013.09.008. [PubMed] [CrossRef] []
  64. 64. Wang K.T., Chen L.G., Wu C.H., Chang C.C., Wang C.C. Gastroprotective activity of atractylenolide III from Atractylodes ovata on ethanol‐induced gastric ulcer in vitro and in vivo. J. Pharm. Pharmacol. 2010;62(3):381–388. doi: 10.1211/jpp.62.03.0014. [PubMed] [CrossRef] []
  65. 65. Cogo L.L., Monteiro C.L.B., Miguel M.D., Miguel O.G., Cunico M.M., Ribeiro M.L., Camargo E.R.D., Kussen G.M.B., Nogueira K.D.S., Costa L.M.D. Anti-Helicobacter pylori activity of plant extracts traditionally used for the treatment of gastrointestinal disorders. Braz. J. Microbiol. 2010;41(2):304–309. [PMC free article] [PubMed] []
  66. 66. Abdelwahab S.I., Mohan S., Abdulla M.A., Sukari M.A., Abdul A.B., Taha M.M.E., Syam S., Ahmad S., Lee K.H. The methanolic extract of Boesenbergia rotunda (L.) Mansf. and its major compound pinostrobin induces anti-ulcerogenic property in vivo: possible involvement of indirect antioxidant action. J. Ethnopharmacol. 2011;137(2):963–970. doi: 10.1016/j.jep.2011.07.010. [PubMed] [CrossRef] []
  67. 67. Epifano F., Menghini L., Pagiotti R., Angelini P., Genovese S., Curini M. In vitro inhibitory activity of boropinic acid against Helicobacter pylori. Bioorg. Med. Chem. Lett. 2006;16(21):5523–5525. doi: 10.1016/j.bmcl.2006.08.043. [PubMed] [CrossRef] []
  68. 68. Galan M.V., Kishan A.A., Silverman A.L. Oral broccoli sprouts for the treatment of Helicobacter pylori infection: a preliminary report. Dig. Dis. Sci. 2004;49(7–8):1088–1090. doi: 10.1023/B:DDAS.0000037792.04787.8a. [PubMed] [CrossRef] []
  69. 69. Banskota A.H., Tezuka Y., Adnyana I.K., Ishii E., Midorikawa K., Matsushige K., Kadota S. Hepatoprotective and anti-Helicobacter pylori activities of constituents from Brazilian propolis. Phytomedicine. 2001;8(1):16–23. doi: 10.1078/0944-7113-00004. [PubMed] [CrossRef] []
  70. 70. Okeleye B.I., Bessong P.O., Ndip R.N. Preliminary phytochemical screening and in vitro anti-Helicobacter pylori activity of extracts of the stem bark of Bridelia micrantha (Hochst., Baill., Euphorbiaceae) Molecules. 2011;16(8):6193–6205. doi: 10.3390/molecules16086193. [PMC free article] [PubMed] [CrossRef] []
  71. 71. Adefuye A.O., Ndip R.N. Phytochemical analysis and antibacterial evaluation of the ethyl acetate extract of the stem bark of Bridelia micrantha. Pharmacogn. Mag. 2013;9(33):45. [PMC free article] [PubMed] []
  72. 72. Bonacorsi C., Da Fonseca L.M., Raddi M.S.G., Kitagawa R.R., Vilegas W. Comparison of Brazilian plants used to treat gastritis on the oxidative burst of Helicobacter pylori-stimulated neutrophil. Evid. Based Complement. Altern. Med. 2013;2013 doi: 10.4103/0973-1296.108139. [PMC free article] [PubMed] [CrossRef] []
  73. 73. Lima Z.P., dos Santos R.D.C., Torres T.U., Sannomiya M., Rodrigues C.M., dos Santos L.C., Pellizzon C.H., Rocha L.R.M., Vilegas W., Brito A.R.M.S., Cardoso C.R.P. Byrsonima fagifolia: an integrative study to validate the gastroprotective, healing, antidiarrheal, antimicrobial and mutagenic action. J. Ethnopharmacol. 2008;120(2):149–160. doi: 10.1016/j.jep.2008.07.047. [PubMed] [CrossRef] []
  74. 74. Santos R.C., Kushima H., Rodrigues C.M., Sannomiya M., Rocha L.R.M., Bauab T.M., Tamashiro J., Vilegas W., Hiruma-Lima C.A. Byrsonima intermedia A. Juss.: gastric and duodenal anti-ulcer, antimicrobial and antidiarrheal effects in experimental rodent models. J. Ethnopharmacol. 2012;140(2):203–212. doi: 10.1016/j.jep.2011.12.008. [PubMed] [CrossRef] []
  75. 75. Lemos L.M.S., Martins T.B., Tanajura G.H., Gazoni V.F., Bonaldo J., Strada C.L., da Silva M.G., Dall’Oglio E.L., de Sousa Júnior P.T., de Oliveira Martins D.T. Evaluation of antiulcer activity of chromanone fraction from Calophyllum brasiliesnse Camb. J. Ethnopharmacol. 2012;141(1):432–439. doi: 10.1016/j.jep.2012.03.006. [PubMed] [CrossRef] []
  76. 76. Takabayashi F., Harada N., Yamada M., Murohisa B., Oguni I. Inhibitory effect of green tea catechins in combination with sucralfate on Helicobacter pylori infection in Mongolian gerbils. J. Gastroenterol. 2004;39(1):61–63. doi: 10.1007/s00535-003-1246-0. [PubMed] [CrossRef] []
  77. 77. Ruggiero P., Rossi G., Tombola F., Pancotto L., Lauretti L., Del Giudice G., Zoratti M. Red wine and green tea reduce H pylori-or VacA-induced gastritis in a mouse model. World J. Gastroenterol.: WJG. 2007;13(3):349. doi: 10.3748/wjg.v13.i3.349. [PMC free article] [PubMed] [CrossRef] []
  78. 78. Nariman F., Eftekhar F., Habibi Z., Massarrat S., Malekzadeh R. Antibacterial activity of twenty Iranian plant extracts against clinical isolates of Helicobacter pylori. Iran. J. Basic Med. Sci. 2009;12(2):105–111. []
  79. 79. Spósito L., Oda F.B., Vieira J.H., Carvalho F.A., dos Santos Ramos M.A., de Castro R.C., Crevelin E.J., Crotti A.E.M., Santos A.G., da Silva P.B., Chorilli M. In vitro and in vivo anti-Helicobacter pylori activity of Casearia sylvestris leaf derivatives. J. Ethnopharmacol. 2019;233:1–12. doi: 10.1016/j.jep.2018.12.032. [PubMed] [CrossRef] []
  80. 80. Shikov A.N., Pozharitskaya O.N., Makarov V.G., Kvetnaya A.S. Antibacterial activity of Chamomilla recutita oil extract against Helicobacter pylori. Phytother. Res. 2008;22(2):252–253. doi: 10.1002/ptr.2243. [PubMed] [CrossRef] []
  81. 81. Stamatis G., Kyriazopoulos P., Golegou S., Basayiannis A., Skaltsas S., Skaltsa H. In vitro anti-Helicobacter pylori activity of Greek herbal medicines. J. Ethnopharmacol. 2003;88(2–3):175–179. doi: 10.1016/S0378-8741(03)00217-4. [PubMed] [CrossRef] []
  82. 82. Mabe K., Yamada M., Oguni I., Takahashi T. In vitro and in vivo activities of tea catechins against Helicobacter pylori. Antimicrob. Agents Chemother. 1999;43(7):1788–1791. doi: 10.1128/AAC.43.7.1788. [PMC free article] [PubMed] [CrossRef] []
  83. 83. Hosseininejad Z., Moghadam S.D., Ebrahimi F., Abdollahi M., Zahedi M.J., Nazari M., Hayatbakhsh M., Adeli S., Sharififar F. In vitro screening of selected Iranian medicinal plants against Helicobacter pylori. Int. J. Green Pharm. (IJGP) 2011;5(4) doi: 10.22377/ijgp.v5i4.214. [CrossRef] []
  84. 84. Ali S.M., Khan A.A., Ahmed I., Musaddiq M., Ahmed K.S., Polasa H., Rao L.V., Habibullah C.M., Sechi L.A., Ahmed N. Antimicrobial activities of Eugenol and Cinnamaldehyde against the human gastric pathogen Helicobacter pylori. Ann. Clin. Microbiol. Antimicrob. 2005;4(1):20. doi: 10.1186/1476-0711-4-20. [PMC free article] [PubMed] [CrossRef] []
  85. 85. Tabak M., Armon R., Neeman I. Cinnamon extracts’ inhibitory effect on Helicobacter pylori. J. Ethnopharmacol. 1999;67(3):269–277. doi: 10.1016/S0378-8741(99)00054-9. [PubMed] [CrossRef] []
  86. 86. Nabati F., Mojab F., Habibi-Rezaei M., Bagherzadeh K., Amanlou M., Yousefi B. Large scale screening of commonly used Iranian traditional medicinal plants against urease activity. Daru J. Pharm. Sci. 2012;20(1):72. doi: 10.1186/2008-2231-20-72. [PMC free article] [PubMed] [CrossRef] []
  87. 87. Yeşilada E., Gürbüz I., Shibata H. Screening of Turkish anti-ulcerogenic folk remedies for anti-Helicobacter pylori activity. J. Ethnopharmacol. 1999;66(3):289–293. doi: 10.1016/S0378-8741(98)00219-0. [PubMed] [CrossRef] []
  88. 88. Ustün O., Ozçelik B., Akyön Y., Abbasoglu U., Yesilada E. Flavonoids with anti-Helicobacter pylori activity from Cistus laurifolius leaves. J. Ethnopharmacol. 2006;108(3):457–461. doi: 10.1016/j.jep.2006.06.001. [PubMed] [CrossRef] []
  89. 89. Bonamin F., Moraes T.M., Dos Santos R.C., Kushima H., Faria F.M., Silva M.A., Junior I.V., Nogueira L., Bauab T.M., Brito A.R.S., da Rocha L.R. The effect of a minor constituent of essential oil from Citrus aurantium: the role of β-myrcene in preventing peptic ulcer disease. Chem. Biol. Interact. 2014;212:11–19. doi: 10.1016/j.cbi.2014.01.009. [PubMed] [CrossRef] []
  90. 90. Rozza A.L., de Mello Moraes T., Kushima H., Tanimoto A., Marques M.O.M., Bauab T.M., Hiruma-Lima C.A., Pellizzon C.H. Gastroprotective mechanisms of Citrus lemon (Rutaceae) essential oil and its majority compounds limonene and β-pinene: involvement of heat-shock protein-70, vasoactive intestinal peptide, glutathione, sulfhydryl compounds, nitric oxide and prostaglandin E2. Chem. Biol. Interact. 2011;189(1–2):82–89. doi: 10.1016/j.cbi.2010.09.031. [PubMed] [CrossRef] []
  91. 91. Poovendran P., Kalaigandhi V., Poongunran E. Antimicrobial activity of the leaves of Cocculus hirsutus against gastric ulcer producing Helicobacter pylori. J. Pharm. Res. 2011;4:4294–4295. doi: 10.1186/s12941-014-0054-0. [CrossRef] []
  92. 92. Njume C., Jide A.A., Ndip R.N. Aqueous and organic solvent-extracts of selected South African medicinal plants possess antimicrobial activity against drug-resistant strains of Helicobacter pylori: inhibitory and bactericidal potential. Int. J. Mol. Sci. 2011;12(9):5652–5665. doi: 10.3390/ijms12095652. [PMC free article] [PubMed] [CrossRef] []
  93. 93. Suleiman M.M., Tauheed M., Babandi J.S., Umar R., Sulaiman M.H., Shittu M., Isa H.I. An in vivo experimental trial to determine the efficacy of stem-bark extract of Khaya senegalensis A. Juss (Meliaceae) for treating gastric ulcer in rat. Int. J. Med. Aromat. Plants. 2013;3(3):352–361. []
  94. 94. Reyes‐Trejo B., Sánchez‐Mendoza M.E., Becerra‐García A.A., Cedillo‐Portugal E., Castillo‐Henkel C., Arrieta J. Bioassay‐guided isolation of an anti‐ulcer diterpenoid from Croton reflexifolius: role of nitric oxide, prostaglandins and sulfhydryls. J. Pharm. Pharmacol. 2008;60(7):931–936. doi: 10.1211/jpp.60.7.0016. [PubMed] [CrossRef] []
  95. 95. Koga T., Kawada H., Utsui Y., Domon H., Ishii C., Yasuda H. In-vitro and in-vivo antibacterial activity of plaunotol, a cytoprotective antiulcer agent, against Helicobacter pylori. J. Antimicrob. Chemother. 1996;37(5):919–929. doi: 10.1093/jac/37.5.919. [PubMed] [CrossRef] []
  96. 96. Nostro A., Cellini L., Bartolomeo S.D., Campli E.D., Grande R., Cannatelli M.A., Marzio L., Alonzo V. Antibacterial effect of plant extracts against Helicobacter pylori. Phytother. Res. 2005;19(3):198–202. doi: 10.1002/ptr.1640. [PubMed] [CrossRef] []
  97. 97. Zaidi S.F.H., Yamada K., Kadowaki M., Usmanghani K., Sugiyama T. Bactericidal activity of medicinal plants, employed for the treatment of gastrointestinal ailments, against Helicobacter pylori. J. Ethnopharmacol. 2009;121(2):286–291. doi: 10.1016/j.jep.2008.11.001. [PubMed] [CrossRef] []
  98. 98. Ohno T., Kita M., Yamaoka Y., Imamura S., Yamamoto T., Mitsufuji S., Kodama T., Kashima K., Imanishi J. Antimicrobial activity of essential oils against Helicobacter pylori. Helicobacter. 2003;8(3):207–215. doi: 10.1046/j.1523-5378.2003.00146.x. [PubMed] [CrossRef] []
  99. 99. Jaguezeski A.M., Perin G., Crecencio R.B., Baldissera M.D., Stefanil L.M., da Silva A.S. Addition of curcumin in dairy sheep diet in the control of subclinical mastitis. Acta Sci. Vet. 2018;46:7. []
  100. 100. Escobedo-Hinojosa W.I., del Carpio J.D., Palacios-Espinosa J.F., Romero I. Contribution to the ethnopharmacological and anti-Helicobacter pylori knowledge of Cyrtocarpa procera Kunth (Anacardiaceae) J. Ethnopharmacol. 2012;143(1):363–371. doi: 10.1016/j.jep.2012.07.001. [PubMed] [CrossRef] []
  101. 101. Kushima H., Nishijima C.M., Rodrigues C.M., Rinaldo D., Sassá M.F., Bauab T.M., Di Stasi L.C., Carlos I.Z., Brito A.R.M.S., Vilegas W., Hiruma-Lima C.A. Davilla elliptica and Davilla nitida: gastroprotective, anti-inflammatory immunomodulatory and anti-Helicobacter pylori action. J. Ethnopharmacol. 2009;123(3):430–438. doi: 10.1016/j.jep.2009.03.031. [PubMed] [CrossRef] []
  102. 102. Bergonzelli G.E., Donnicola D., Porta N., Corthesy-Theulaz I.E. Essential oils as components of a diet-based approach to management of Helicobacter infection. Antimicrob. Agents Chemother. 2003;47(10):3240–3246. doi: 10.1128/AAC.47.10.3240-3246.2003. [PMC free article] [PubMed] [CrossRef] []
  103. 103. Uyub A.M., Nwachukwu I.N., Azlan A.A., Fariza S.S. 2010. In-Vitro Antibacterial Activity and Cytotoxicity of Selected Medicinal Plant Extracts from Penang Island Malaysia on Metronidazole-Resistant-Helicobacter Pylori and Some Pathogenic Bacteria.http://hdl.handle.net/10125/21002 []
  104. 104. Ramadan M.A., Safwat N.A. Antihelicobacter activity of a flavonoid compound isolated from Desmostachya bipinnata. Aust. J. Basic Appl. Sci. 2009;3(3):2270–2277. https://www.researchgate.net/publication/281526897 []
  105. 105. Ibrahim N.H., Awaad A.S., Alnafisah R.A., Alqasoumi S.I., El-Meligy R.M., Mahmoud A.Z. In–vitro activity of Desmostachya bipinnata (L.) Stapf successive extracts against Helicobacter pylori clinical isolates. Saudi Pharm. J. 2018;26(4):535–540. doi: 10.1016/j.jsps.2018.02.002. [PMC free article] [PubMed] [CrossRef] []
  106. 106. Miguel G., Faleiro L., Cavaleiro C., Salgueiro L., Casanova J. Susceptibility of Helicobacter pylori to essential oil of Dittrichia viscosa subsp. revoluta. Phytother. Res. 2008;22(2):259–263. doi: 10.1002/ptr.2284. [PubMed] [CrossRef] []
  107. 107. Adeniyi C.B.A., Lawal T.O., Mahady G.B. In vitro susceptibility of Helicobacter pylori to extracts of Eucalyptus camaldulensis and Eucalyptus torelliana. Pharm. Biol. 2009;47(1):99–102. doi: 10.1080/13880200802448708. [PMC free article] [PubMed] [CrossRef] []
  108. 108. Li Y., Xu C., Zhang Q., Liu J.Y., Tan R.X. In vitro anti-Helicobacter pylori action of 30 Chinese herbal medicines used to treat ulcer diseases. J. Ethnopharmacol. 2005;98(3):329–333. doi: 10.1016/j.jep.2005.01.020. [PubMed] [CrossRef] []
  109. 109. Sánchez-Mendoza M.E., Reyes-Trejo B., Sánchez-Gómez P., Rodríguez-Silverio J., Castillo-Henkel C., Cervantes-Cuevas H., Arrieta J. Bioassay-guided isolation of an anti-ulcer chromene from Eupatorium aschenbornianum: role of nitric oxide, prostaglandins and sulfydryls. Fitoterapia. 2010;81(1):66–71. doi: 10.1016/j.fitote.2009.07.009. [PubMed] [CrossRef] []
  110. 110. Hamasaki N., Ishii E., Tominaga K., Tezuka Y., Nagaoka T., Kadota S., Kuroki T., Yano I. Highly selective antibacterial activity of novel alkyl quinolone alkaloids from a Chinese herbal medicine, Gosyuyu (Wu-Chu-Yu), against Helicobacter pylori in vitro. Microbiol. Immunol. 2000;44(1):9–15. https://www.jstage.jst.go.jp/article/mandi1977/44/1/44_1_9/_article/-char/ja/ [PubMed] []
  111. 111. Basile A., Conte B., Rigano D., Senatore F., Sorbo S. Antibacterial and antifungal properties of acetonic extract of Feijoa sellowiana fruits and its effect on Helicobacter pylori growth. J. Med. Food. 2010;13(1):189–195. doi: 10.1089/jmf.2008.0301. [PubMed] [CrossRef] []
  112. 112. Basile A., Sorbo S., Spadaro V., Bruno M., Maggio A., Faraone N., Rosselli S. Antimicrobial and antioxidant activities of coumarins from the roots of Ferulago campestris (Apiaceae) Molecules. 2009;14(3):939–952. doi: 10.3390/molecules14030939. [PMC free article] [PubMed] [CrossRef] []
  113. 113. Rosselli S., Maggio A.M., Faraone N., Spadaro V., Morris-Natschke S.L., Bastow K.F., Lee K.H., Bruno M. The cytotoxic properties of natural coumarins isolated from roots of Ferulago campestris (Apiaceae) and of synthetic ester derivatives of aegelinol. Nat. Prod. Commun. 2009;4(12) doi: 10.1177/1934578X0900401219. p.1934578X0900401219. [PubMed] [CrossRef] []
  114. 114. Jadhav S.G., Meshram R.J., Gond D.S., Gacche R.N. Inhibition of growth of Helicobacter pylori and its urease by coumarin derivatives: molecular docking analysis. J. Pharm. Res. 2013;7(8):705–711. doi: 10.1016/j.jopr.2013.09.002. [CrossRef] []
  115. 115. Kawase M., Tanaka T., Sohara Y., Tani S., Sakagami H., Hauer H., Chatterjee S.S. Structural requirements of hydroxylated coumarins for in vitro anti-Helicobacter pylori activity. In Vivo. 2003;17(5):509–512. [PubMed] []
  116. 116. Niero R., Dal Molin M.M., Silva S., Damian N.S., Maia L.O., Delle Monache F., Cechinel Filho V., de Andrade S.F. Gastroprotective effects of extracts and guttiferone A isolated from Garcinia achachairu Rusby (Clusiaceae) against experimentally induced gastric lesions in mice. Naunyn Schmiedebergs Arch. Pharmacol. 2012;385(11):1103–1109. doi: 10.1007/s00210-012-0788-1. [PubMed] [CrossRef] []
  117. 117. Zhang X.Q., Gu H.M., Li X.Z., Xu Z.N., Chen Y.S., Li Y. Anti-Helicobacter pylori compounds from the ethanol extracts of Geranium wilfordii. J. Ethnopharmacol. 2013;147(1):204–207. doi: 10.1016/j.jep.2013.02.032. [PubMed] [CrossRef] []
  118. 118. Shahani S., Monsef-Esfahani H.R., Saeidnia S., Saniee P., Siavoshi F., Foroumadi A., Samadi N., Gohari A.R. Anti-Helicobacter pylori activity of the methanolic extract of Geum iranicum and its main compounds. Z. Naturforschung C. 2012;67(3–4):172–180. doi: 10.1515/znc-2012-3-409. [PubMed] [CrossRef] []
  119. 119. Fukai T., Marumo A., Kaitou K., Kanda T., Terada S., Nomura T. Anti-Helicobacter pylori flavonoids from licorice extract. Life Sci. 2002;71(12):1449–1463. [PubMed] []
  120. 120. Aly A.M., Al-Alousi L., Salem H.A. Licorice: a possible anti-inflammatory and anti-ulcer drug. AAPS PharmSciTech. 2005;6(1):E74–E82. doi: 10.1016/S0024-3205(02)01864-7. [PMC free article] [PubMed] [CrossRef] []
  121. 121. de Mello Moraes T., Rodrigues C.M., Kushima H., Bauab T.M., Villegas W., Pellizzon C.H., Brito A.R.M.S., Hiruma-Lima C.A. Hancornia speciosa: indications of gastroprotective, healing and anti-Helicobacter pylori actions. J. Ethnopharmacol. 2008;120(2):161–168. doi: 10.1016/j.jep.2008.08.001. [PubMed] [CrossRef] []
  122. 122. Shang X., Tan Q., Liu R., Yu K., Li P., Zhao G.P. In vitro anti-Helicobacter pylori effects of medicinal mushroom extracts, with special emphasis on the Lion’s Mane mushroom, Hericium erinaceus (higher Basidiomycetes) Int. J. Med. Mushrooms. 2013;15(2):165–174. doi: 10.1615/IntJMedMushr.v15.i2.50. [PubMed] [CrossRef] []
  123. 123. Mahady G.B., Pendland S.L., Stoia A., Chadwick L.R. In vitro susceptibility of Helicobacter pylori to isoquinoline alkaloids from Sanguinaria canadensis and Hydrastis canadensis. Phytother. Res. 2003;17(3):217–221. doi: 10.1002/ptr.1108. [PubMed] [CrossRef] []
  124. 124. Mohtar M., Johari S.A., Li A.R., Isa M.M., Mustafa S., Ali A.M., Basri D.F. Inhibitory and resistance-modifying potential of plant-based alkaloids against methicillin-resistant Staphylococcus aureus (MRSA) Curr. Microbiol. 2009;59(2):181–186. doi: 10.1007/s00284-009-9416-9. [PubMed] [CrossRef] []
  125. 125. Markham P.N., Westhaus E., Klyachko K., Johnson M.E., Neyfakh A.A. Multiple novel inhibitors of the NorA multidrug transporter of Staphylococcus aureus. Antimicrob. Agents Chemother. 1999;43(10):2404–2408. doi: 10.1128/AAC.43.10.2404. [PMC free article] [PubMed] [CrossRef] []
  126. 126. Rao K.N., Venkatachalam S.R. Inhibition of dihydrofolate reductase and cell growth activity by the phenanthroindolizidine alkaloids pergularinine and tylophorinidine: the in vitro cytotoxicity of these plant alkaloids and their potential as antimicrobial and anticancer agents. Toxicol. Vitro. 2000;14(1):53–59. doi: 10.1016/S0887-2333(99)00092-2. [PubMed] [CrossRef] []
  127. 127. Vera-Arzave C., Antonio L.C., Arrieta J., Cruz-Hernández G., Velázquez-Méndez A.M., Reyes-Ramírez A., Sánchez-Mendoza M.E. Gastroprotection of suaveolol, isolated from Hyptis suaveolens, against ethanol-induced gastric lesions in Wistar rats: role of prostaglandins, nitric oxide and sulfhydryls. Molecules. 2012;17(8):8917–8927. doi: 10.3390/molecules17088917. [PMC free article] [PubMed] [CrossRef] []
  128. 128. Lu M.C., Chiu H.F., Lin C.P., Shen Y.C., Venkatakrishnan K., Wang C.K. Anti-Helicobacter pylori effect of various extracts of ixeris chinensis on inflammatory markers in human gastric epithelial AGS cells. J. Herb. Med. 2018;11:60–70. doi: 10.1016/j.hermed.2017.08.002. [CrossRef] []
  129. 129. Pertino M., Schmeda-Hirschmann G., Rodríguez J.A., Theoduloz C. Gastroprotective effect and cytotoxicity of terpenes from the Paraguayan crude drug “yagua rova” (Jatropha isabelli) J. Ethnopharmacol. 2007;111(3):553–559. doi: 10.1016/j.jep.2007.01.003. [PubMed] [CrossRef] []
  130. 130. Hajimahmoodi M., Shams-Ardakani M., Saniee P., Siavoshi F., Mehrabani M., Hosseinzadeh H., Foroumadi P., Safavi M., Khanavi M., Akbarzadeh T., Shafiee A. In vitro antibacterial activity of some Iranian medicinal plant extracts against Helicobacter pylori. Nat. Prod. Res. 2011;25(11):1059–1066. doi: 10.1080/14786419.2010.501763. [PubMed] [CrossRef] []
  131. 131. Stege P.W., Davicino R.C., Vega A.E., Casali Y.A., Correa S., Micalizzi B. Antimicrobial activity of aqueous extracts of Larrea divaricata Cav (jarilla) against Helicobacter pylori. Phytomedicine. 2006;13(9–10):724–727. doi: 10.1016/j.phymed.2005.06.008. [PubMed] [CrossRef] []
  132. 132. Bae E.A., Han M.J., Kim N.J., Kim D.H. Anti-Helicobacter pylori activity of hearbal medicines. Biol. Pharm. Bull. 1998;21(9):990–992. doi: 10.1248/bpb.21.990. [PubMed] [CrossRef] []
  133. 133. Neelima N., Sudhakar M., Patil M.B., Lakshmi B.V.S. Anti-ulcer activity and HPTLC analysis of Mangifera indica L. leaves. Int. J. Pharm. Phytopharm. Res. 2012;1(4):146–155. []
  134. 134. Carvalho A.C.S., Guedes M.M., de Souza A.L., Trevisan M.T., Lima A.F., Santos F.A., Rao V.S. Gastroprotective effect of mangiferin, a xanthonoid from Mangifera indica, against gastric injury induced by ethanol and indomethacin in rodents. Planta Med. 2007;73(13):1372–1376. doi: 10.1055/s-2007-990231. [PubMed] [CrossRef] []
  135. 135. Abdulla M.A., Ali H.M., Ahmed K.A.A., Noor S.M., Ismail S. 2009. Evaluation of the Anti-Ulcer Activities of Morus alba Extracts in Experimen-Tally-Induced Gastric Ulcer in Rats. []
  136. 136. Ahmad A., Gupta G., Afzal M., Kazmi I., Anwar F. Antiulcer and antioxidant activities of a new steroid from Morus alba. Life Sci. 2013;92(3):202–210. doi: 10.1016/j.lfs.2012.11.020. [PubMed] [CrossRef] []
  137. 137. Sidahmed H.M.A., Azizan A.H.S., Mohan S., Abdulla M.A., Abdelwahab S.I., Taha M.M.E., Hadi A.H.A., Ketuly K.A., Hashim N.M., Loke M.F., Vadivelu J. Gastroprotective effect of desmosdumotin C isolated from Mitrella kentii against ethanol-induced gastric mucosal hemorrhage in rats: possible involvement of glutathione, heat-shock protein-70, sulfhydryl compounds, nitric oxide, and anti-Helicobacter pylori activity. BMC Complement. Altern. Med. 2013;13(1):183. doi: 10.1186/1472-6882-13-183. [PMC free article] [PubMed] [CrossRef] []
  138. 138. Lewis D.A., Shaw G.P. A natural flavonoid and synthetic analogues protect the gastric mucosa from aspirin-induced erosions. J. Nutr. Biochem. 2001;12(2):95–100. doi: 10.1016/S0955-2863(00)00133-9. [PubMed] [CrossRef] []
  139. 139. Jain D.L., Baheti A.M., Parakh S.R., Ingale S.P., Ingale P.L. PHCOG MAG.: research article study of antacid and diuretic activity of ash and extracts of Musa sapientum L. fruit peel. Phcog. Mag. 2007;3(10):116. []
  140. 140. Bhamarapravati S., Pendland S.L., Mahady G.B. Extracts of spice and food plants from Thai traditional medicine inhibit the growth of the human carcinogen Helicobacter pylori. In Vivo (Athens, Greece) 2003;17(6):541–544. https://europepmc.org/article/med/14758718 [PubMed] []
  141. 141. Ohsaki A., Takashima J., Chiba N., Kawamura M. Microanalysis of a selective potent anti-Helicobacter pylori compound in a Brazilian medicinal plant, Myroxylon peruiferum and the activity of analogues. Bioorg. Med. Chem. Lett. 1999;9(8):1109–1112. doi: 10.1016/S0960-894X(99)00141-9. [PubMed] [CrossRef] []
  142. 142. Deriu A., Branca G., Molicotti P., Pintore G., Chessa M., Tirillini B., Paglietti B., Mura A., Sechi L.A., Fadda G., Zanetti S. In vitro activity of essential oil of Myrtus communis L. against Helicobacter pylori. Int. J. Antimicrob. Agents. 2007;30(6):562. doi: 10.1016/j.ijantimicag.2007.07.005. [PubMed] [CrossRef] []
  143. 143. Sudjana A.N., D’Orazio C., Ryan V., Rasool N., Ng J., Islam N., Riley T.V., Hammer K.A. Antimicrobial activity of commercial Olea europaea (olive) leaf extract. Int. J. Antimicrob. Agents. 2009;33(5):461–463. doi: 10.1016/j.ijantimicag.2008.10.026. [PubMed] [CrossRef] []
  144. 144. Singh S., Majumdar D.K. Evaluation of the gastric antiulcer activity of fixed oil of Ocimum sanctum (Holy Basil) J. Ethnopharmacol. 1999;65(1):13–19. doi: 10.1016/S0378-8741(98)00142-1. [PubMed] [CrossRef] []
  145. 145. Sumbul S., Ahmad M.A., Mohd A., Mohd A. Role of phenolic compounds in peptic ulcer: an overview. J. Pharm. Bioallied Sci. 2011;3(3):361. doi: 10.4103/0975-7406.84437. [PMC free article] [PubMed] [CrossRef] []
  146. 146. Ares J.J., Outt P.E., Randall J.L., Johnston J.N., Murray P.D., O’Brien L.M., Weisshaar P.S., Ems B.L. Synthesis and biological evaluation of flavonoids and related compounds as gastroprotective agents. Bioorg. Med. Chem. Lett. 1996;6(8):995–998. doi: 10.1016/0960-894X(96)00134-5. [CrossRef] []
  147. 147. Afroz S., Yagi A., Fujikawa K., Rahman M.M., Morito K., Fukuta T., Watanabe S., Kiyokage E., Toida K., Shimizu T., Ishida T. Lysophosphatidic acid in medicinal herbs enhances prostaglandin E2 and protects against indomethacin-induced gastric cell damage in vivo and in vitro. Prostaglandins Other Lipid Mediat. 2018;135:36–44. doi: 10.1016/j.prostaglandins.2018.01.003. [PubMed] [CrossRef] []
  148. 148. Sun X.B., Matsumolo T., Yamada H. Purification of an anti-ulcer polysaccharide from the leaves of Panax ginseng. Planta Med. 1992;58(05):445–448. doi: 10.1055/s-2006-961510. [PubMed] [CrossRef] []
  149. 149. Yamada H. Pectic polysaccharides from Chinese herbs: structure and biological activity. Carbohydr. Polym. 1994;25(4):269–276. doi: 10.1016/0144-8617(94)90052-3. [CrossRef] []
  150. 150. Cowan M.M. Plant products as antimicrobial agents. Clin. Microbiol. Rev. 1999;12(4):564–582. doi: 10.1128/CMR.12.4.564. [PMC free article] [PubMed] [CrossRef] []
  151. 151. Rojas-Martínez R., Arrieta J., Cruz-Antonio L., Arrieta-Baez D., Velázquez-Méndez A., Sánchez-Mendoza M. Dillapiole, isolated from Peperomia pellucida, shows gastroprotector activity against ethanol-induced gastric lesions in Wistar rats. Molecules. 2013;18(9):11327–11337. doi: 10.3390/molecules180911327. [PMC free article] [PubMed] [CrossRef] []
  152. 152. Ranilla L.G., Apostolidis E., Shetty K. Antimicrobial activity of an Amazon medicinal plant (Chancapiedra) (Phyllanthus niruri L.) against Helicobacter pylori and lactic acid bacteria. Phytother. Res. 2012;26(6):791–799. doi: 10.1002/ptr.3646. [PubMed] [CrossRef] []
  153. 153. Wang Y., Wang S.L., Zhang J.Y., Song X.N., Zhang Z.Y., Li J.F., Li S. Anti-ulcer and anti-Helicobacter pylori potentials of the ethyl acetate fraction of Physalis alkekengi L. var. franchetii (Solanaceae) in rodent. J. Ethnopharmacol. 2018;211:197–206. doi: 10.1016/j.jep.2017.09.004. [PubMed] [CrossRef] []
  154. 154. Quílez A., Berenguer B., Gilardoni G., Souccar C., De Mendonça S., Oliveira L.F.S., Martín-Calero M.J., Vidari G. Anti-secretory, anti-inflammatory and anti-Helicobacter pylori activities of several fractions isolated from Piper carpunya Ruiz & Pav. J. Ethnopharmacol. 2010;128(3):583–589. doi: 10.1016/j.jep.2010.01.060. [PubMed] [CrossRef] []
  155. 155. Rüegg T., Calderón A.I., Queiroz E.F., Solis P.N., Marston A., Rivas F., Ortega-Barría E., Hostettmann K., Gupta M.P. 3-Farnesyl-2-hydroxybenzoic acid is a new anti-Helicobacter pylori compound from Piper multiplinervium. J. Ethnopharmacol. 2006;103(3):461–467. doi: 10.1016/j.jep.2005.09.014. [PubMed] [CrossRef] []
  156. 156. Al-Said M.S., Ageel A.M., Parmar N.S., Tariq M. Evaluation of mastic, a crude drug obtained from Pistacia lentiscus for gastric and duodenal anti-ulcer activity. J. Ethnopharmacol. 1986;15(3):271–278. doi: 10.1016/0378-8741(86)90165-0. [PubMed] [CrossRef] []
  157. 157. Marone P., Bono L., Leone E., Bona S., Carretto E., Perversi L. Bactericidal activity of Pistacia lentiscus mastic gum against Helicobacter pylori. J. Chemother. 2001;13(6):611–614. doi: 10.1179/joc.2001.13.6.611. [PubMed] [CrossRef] []
  158. 158. Dabos K.J., Sfika E., Vlatta L.J., Giannikopoulos G. The effect of mastic gum on Helicobacter pylori: a randomized pilot study. Phytomedicine. 2010;17(3–4):296–299. doi: 10.1016/j.phymed.2009.09.010. [PubMed] [CrossRef] []
  159. 159. Paraschos S., Magiatis P., Mitakou S., Petraki K., Kalliaropoulos A., Maragkoudakis P., Mentis A., Sgouras D., Skaltsounis A.L. In vitro and in vivo activities of Chios mastic gum extracts and constituents against Helicobacter pylori. Antimicrob. Agents Chemother. 2007;51(2):551–559. doi: 10.1128/AAC.00642-06. [PMC free article] [PubMed] [CrossRef] []
  160. 160. de Araújo Rodrigues P., de Morais S.M., de Souza C.M., Silva A.R.A., de Andrade G.M., Silva M.G.V., Albuquerque R.L., Rao V.S., Santos F.A. Gastroprotective effect of barbatusin and 3-beta-hydroxy-3-deoxibarbatusin, quinonoid diterpenes isolated from Plectranthus grandis, in ethanol-induced gastric lesions in mice. J. Ethnopharmacol. 2010;127(3):725–730. doi: 10.1016/j.jep.2009.11.031. [PubMed] [CrossRef] []
  161. 161. Wang Y.C., Huang T.L. High-performance liquid chromatography for quantification of plumbagin, an anti-Helicobacter pylori compound of Plumbago zeylanica L. J. Chromatogr. A. 2005;1094(1–2):99–104. doi: 10.1016/j.chroma.2005.07.092. [PubMed] [CrossRef] [
  162. 162. Klein L.C., Gandolfi R.B., Santin J.R., Lemos M., Cechinel Filho V., de Andrade S.F. Antiulcerogenic activity of extract, fractions, and some compounds obtained from Polygala cyparissias St. Hillaire & Moquin (Polygalaceae) Naunyn Schmiedeberg’s Arch. Pharmacol. 2010;381(2):121–126. doi: 10.1007/s00210-009-0485-x. [PubMed] [CrossRef] []
  163. 163. Hashimoto T., Aga H., Chaen H., Fukuda S., Kurimoto M. Isolation and identification of anti-Helicobacter pylori compounds from Polygonum tinctorium Lour. Nat. Med.= 生薬學雜誌 1999;53(1):27–31. []
  164. 164. Tomczyk M., Leszczyńska K., Jakoniuk P. Antimicrobial activity of Potentilla species. Fitoterapia. 2008;79(7–8):592–594. doi: 10.1016/j.fitote.2008.06.006. [PubMed] [CrossRef] []
  165. 165. Bisignano C., Filocamo A., La Camera E., Zummo S., Fera M.T., Mandalari G. Antibacterial activities of almond skins on cagA-positive and-negative clinical isolates of Helicobacter pylori. BMC Microbiol. 2013;13(1):103. doi: 10.1186/1471-2180-13-103. [PMC free article] [PubMed] [CrossRef] []
  166. 166. Yin S., Fan C.Q., Dong L., Yue J.M. Psoracorylifols A–E, five novel compounds with activity against Helicobacter pylori from seeds of Psoralea corylifolia. Tetrahedron. 2006;62(11):2569–2575. doi: 10.1016/j.tet.2005.12.041. [CrossRef] []
  167. 167. De Leo M., De Tommasi N., Sanogo R., D’Angelo V., Germanò M.P., Bisignano G., Braca A. Triterpenoid saponins from Pteleopsis suberosa stem bark. Phytochemistry. 2006;67(24):2623–2629. doi: 10.1016/j.phytochem.2006.07.017. [PubMed] [CrossRef] []
  168. 168. Voravuthikunchai S.P., Limsuwan S., Mitchell H. Effects of Punica granatum pericarps and Quercus infectoria nutgalls on cell surface hydrophobicity and cell survival of Helicobacter pylori. J. Health Sci. 2006;52(2):154–159. doi: 10.1248/jhs.52.154. [CrossRef] []
  169. 169. Moghaddam M.N. In vitro inhibition of Helicobacter pylori by some spices and medicinal plants used in Iran. Glob. J. Pharmacol. 2011;5(3):176–180. []
  170. 170. Mazzolin L.P., Nasser A.L.M., Moraes T.M., Santos R.C., Nishijima C.M., Santos F.V., Varanda E.A., Bauab T.M., da Rocha L.R.M., Di Stasi L.C., Vilegas W. Qualea parviflora Mart.: an integrative study to validate the gastroprotective, antidiarrheal, antihemorragic and mutagenic action. J. Ethnopharmacol. 2010;127(2):508–514. doi: 10.1016/j.jep.2009.10.005. [PubMed] [CrossRef] []
  171. 171. Kadota S., Basnet P., Ishii E., Tamura T., Namba T. Antibacterial activity of trichorabdal A from Rabdosia trichocarpa against Helicobacter pylori. Zent. Bakteriol. 1997;286(1):63–67. doi: 10.1016/S0934-8840(97)80076-X. [PubMed] [CrossRef] []
  172. 172. Chung J.G., Tsou M.F., Wang H.H., Lo H.H., Hsieh S.E., Yen Y.S., Wu L.T., Chang S.H., Ho C.C., Hung C.F. Rhein affects arylamine N‐acetyltransferase activity in Helicobacter pylori from peptic ulcer patients. J. Appl.Toxicol. 1998;18(March (2)):117–123. doi: 10.1002/(SICI)1099-1263(199805/06)18:3<179::AID-JAT494>3.0.CO;2-W. Chichester: John Wiley & Sons, Ltd. [PubMed] [CrossRef] []
  173. 173. Berté P.E., da Silva Lopes J., Comandulli N.G., Rangel D.W., Delle Monache F., Cechinel Filho V., Niero R., de Andrade S.F. Evaluation of the gastroprotective activity of the extracts, fractions, and pure compounds obtained from aerial parts of Rubus imperialis in different experimental models. Naunyn Schmiedebergs Arch. Pharmacol. 2014;387(4):313–319. doi: 10.1007/s00210-013-0954-0. [PubMed] [CrossRef] []
  174. 174. Atapour M., Zahedi M.J., Mehrabani M., Safavi M., Keyvanfard V., Foroughi A., Siavoshi F., Foroumadi A. In vitro susceptibility of the Gram-negative bacterium Helicobacter pylori to extracts of Iranian medicinal plants. Pharm. Biol. 2009;47(1):77–80. doi: 10.1080/13880200802434401. [CrossRef] []
  175. 175. Gharashi A. vol. 295. Tehran University of Medical Sciences; 2008. (Al-mogez-dar-tebb. Tehran: Translated by Tafghad Khabbaz R). []
  176. 176. Ochi T., Shibata H., Higuti T., Kodama K.H., Kusumi T., Takaishi Y. Anti-Helicobacter pylori compounds from Santalum album. J. Nat. Prod. 2005;68(6):819–824. doi: 10.1021/np040188q. [PubMed] [CrossRef] []
  177. 177. La Casa C., Villegas I., De La Lastra C.A., Motilva V., Calero M.M. Evidence for protective and antioxidant properties of rutin, a natural flavone, against ethanol induced gastric lesions. J. Ethnopharmacol. 2000;71(1–2):45–53. doi: 10.1016/S0378-8741(99)00174-9. [PubMed] [CrossRef] []
  178. 178. Njume C., Afolayan A.J., Green E., Ndip R.N. Volatile compounds in the stem bark of Sclerocarya birrea (Anacardiaceae) possess antimicrobial activity against drug-resistant strains of Helicobacter pylori. Int. J. Antimicrob. Agents. 2011;38(4):319–324. doi: 10.1016/j.ijantimicag.2011.05.002. [PubMed] [CrossRef] []
  179. 179. Júnior G.M.V., da Rocha C.Q., de Souza Rodrigues T., Hiruma-Lima C.A., Vilegas W. New steroidal saponins and antiulcer activity from Solanum paniculatum L. Food Chem. 2015;186:160–167. doi: 10.1016/j.foodchem.2014.08.005. [PubMed] [CrossRef] []
  180. 180. Areche C., Schmeda‐Hirschmann G., Theoduloz C., Rodríguez J.A. Gastroprotective effect and cytotoxicity of abietane diterpenes from the Chilean Lamiaceae sphacele chamaedryoides (Balbis) Briq. J. Pharm. Pharmacol. 2009;61(12):1689–1697. doi: 10.1211/jpp.61.12.0015. [PubMed] [CrossRef] []
  181. 181. Khanavi M., Safavi M., Siavoi F., Fallah Tafti A., Hajimahmoodi M., Hadjiakhoondi A., Rezazadeh S., Foroumadi A. Evaluation of anti-Helicobacter pylori activity of methanol extracts of some species of Stachys and Melia. J. Med. Plants. 2008;4(28):74–80. []
  182. 182. Bonamin F., Moraes T.M., Kushima H., Silva M.A., Rozza A.L., Pellizzon C.H., Bauab T.M., Rocha L.R.M., Vilegas W., Hiruma-Lima C.A. Can a Strychnos species be used as antiulcer agent? Ulcer healing action from alkaloid fraction of Strychnos pseudoquina St. Hil.(Loganiaceae) J. Ethnopharmacol. 2011;138(1):47–52. doi: 10.1016/j.jep.2011.08.020. [PubMed] [CrossRef] []
  183. 183. Magaji R.A., Okasha M.A.M., Abubakar M.S., Fatihu M.Y. Anti-ulcerogenic and anti-secretory activity of the n-butanol portion of Syzygiumaromaticum in rat. Nig. J. Pharm. Sci. 2007;6:119–126. []
  184. 184. Babu T.H., Manjulatha K., Kumar G.S., Hymavathi A., Tiwari A.K., Purohit M., Rao J.M., Babu K.S. Gastroprotective flavonoid constituents from Oroxylum indicum Vent. Bioorg. Med. Chem. Lett. 2010;20(1):117–120. doi: 10.1016/j.bmcl.2009.11.024. [PubMed] [CrossRef] []
  185. 185. Park B.S., Lee H.K., Lee S.E., Piao X.L., Takeoka G.R., Wong R.Y., Ahn Y.J., Kim J.H. Antibacterial activity of Tabebuia impetiginosa Martius ex DC (Taheebo) against Helicobacter pylori. J. Ethnopharmacol. 2006;105(1–2):255–262. doi: 10.1016/j.jep.2005.11.005. [PubMed] [CrossRef] []
  186. 186. Chatterjee A., Khatua S., Chatterjee S., Mukherjee S., Mukherjee A., Paloi S., Acharya K., Bandyopadhyay S.K. Polysaccharide-rich fraction of Termitomyces eurhizus accelerate healing of indomethacin induced gastric ulcer in mice. Glycoconj. J. 2013;30(8):759–768. doi: 10.1007/s10719-013-9479-5. [PubMed] [CrossRef] []
  187. 187. Fabry W., Okemo P., Ansorg R. Activity of East African medicinal plants against Helicobacter pylori. Chemotherapy. 1996;42(5):315–317. doi: 10.1159/000239460. [PubMed] [CrossRef] []
  188. 188. Malekzadeh F., Ehsanifar H., Shahamat M., Levin M., Colwell R.R. Antibacterial activity of black myrobalan (Terminalia chebula Retz) against Helicobacter pylori. Int. J. Antimicrob. Agents. 2001;18(1):85–88. doi: 10.1016/S0924-8579(01)00352-1. [PubMed] [CrossRef] []
  189. 189. Mishra V., Agrawal M., Onasanwo S.A., Madhur G., Rastogi P., Pandey H.P., Palit G., Narender T. Anti-secretory and cyto-protective effects of chebulinic acid isolated from the fruits of Terminalia chebula on gastric ulcers. Phytomedicine. 2013;20(6):506–511. doi: 10.1016/j.phymed.2013.01.002. [PubMed] [CrossRef] []
  190. 190. Bag A., Bhattacharyya S.K., Chattopadhyay R.R. The development of Terminalia chebula Retz. (Combretaceae) in clinical research. Asian Pac. J. Trop. Biomed. 2013;3(3):244–252. doi: 10.1016/S2221-1691(13)60059-3. [PMC free article] [PubMed] [CrossRef] []
  191. 191. Esmaeili D., Mobarez A.M., Tohidpour A. Anti-Helicobacter pylori activities of shoya powder and essential oils of thymus vulgaris and eucalyptus globulus. Open Microbiol. J. 2012;6:65. doi: 10.2174/1874285801206010065. [PMC free article] [PubMed] [CrossRef] []
  192. 192. Sánchez-Mendoza M.E., Reyes-Ramírez A., Cruz Antonio L., Martínez Jiménez L., Rodríguez-Silverio J., Arrieta J. Bioassay-guided isolation of an anti-ulcer compound, tagitinin C, from Tithonia diversifolia: role of nitric oxide, prostaglandins and sulfhydryls. Molecules. 2011;16(1):665–674. doi: 10.3390/molecules16010665. [PMC free article] [PubMed] [CrossRef] []
  193. 193. Nariman F., Eftekhar F., Habibi Z., Falsafi T. Anti-Helicobacter pylori activities of six Iranian plants. Helicobacter. 2004;9(2):146–151. doi: 10.1111/j.1083-4389.2004.00211.x. [PubMed] [CrossRef] []
  194. 194. Burger O., Ofek I., Tabak M., Weiss E.I., Sharon N., Neeman I. A high molecular mass constituent of cranberry juice inhibits Helicobacter pylori adhesion to human gastric mucus. FEMS Immunol. Med. Microbiol. 2000;29(4):295–301. doi: 10.1111/j.1574-695X.2000.tb01537.x. [PubMed] [CrossRef] []
  195. 195. Shmuely H., Burger O., Neeman I., Yahav J., Samra Z., Niv Y., Sharon N., Weiss E., Athamna A., Tabak M., Ofek I. Susceptibility of Helicobacter pylori isolates to the antiadhesion activity of a high-molecular-weight constituent of cranberry. Diagn. Microbiol. Infect. Dis. 2004;50(4):231–235. doi: 10.1016/j.diagmicrobio.2004.08.011. [PubMed] [CrossRef] []
  196. 196. Ghannadi A., Sajjadi S.E., Abedi D., Yousefi J., Daraei-Ardekani R. The in vitro activity of seven Iranian plants of the Lamiaceae family against Helicobacter pylori. Niger. J. Nat. Prod. Med. 2004;8(1):40–42. doi: 10.4314/njnpm.v8i1.11812. [CrossRef] []
  197. 197. Backon J. Ginger: inhibition of thromboxane synthetase and stimulation of prostacyclin: relevance for medicine and psychiatry. Med. Hypotheses. 1986;20(3):271–278. doi: 10.1016/0306-9877(86)90043-5. [PubMed] [CrossRef] []
  198. 198. Johji Y., Michihiko M., Rong H.Q., Hisashi M., Hajime F. The anti-ulcer effect in rats of ginger constituents. J. Ethnopharmacol. 1988;23(2–3):299–304. doi: 10.1016/0378-8741(88)90009-8. [PubMed] [CrossRef] []
  199. 199. Al-Yahya M.A., Rafatullah S., Mossa J.S., Ageel A.M., Parmar N.S., Tariq M. Gastroprotective activity of ginger zingiber officinale rosc., in albino rats. Am. J. Chin. Med. 1989;17(01n02):51–56. doi: 10.1142/S0192415X89000097. [PubMed] [CrossRef] []
  200. 200. Yoshikawa M., Hatakeyama S., Taniguchi K., Matuda H., Yamahara J. 6-gingesulfonic acid, a new anti-ulcer principle, and gingerglycolipids A, B and C, three new monoacyldigalactosylglycerols, from Zingiberis rhizoma originating in Taiwan. Chem. Pharm. Bull. 1992;40(8):2239–2241. doi: 10.1248/cpb.40.2239. [PubMed] [CrossRef] []
  201. 201. Yoshikawa M., Yamaguchi S., Kunimi K., Matsuda H., Okuno Y., Yamahara J., Murakami N. Stomachic principles in ginger. III. An anti-ulcer principle, 6-gingesulfonic acid, and three monoacyldigalactosylglycerols, gingerglycolipids A, B, and C, from Zingiberis Rhizoma originating in Taiwan. Chem. Pharm. Bull. 1994;42(6):1226–1230. doi: 10.1248/cpb.42.1226. [PubMed] [CrossRef] []
  202. 202. Banerjee S., Mullick H.I., Banerjee J., Ghosh A. Zingiber officinale: ‘a natural gold’ Int. J. Pharm. Biol.-Sci. 2011;2:283–294. []

 

 


Liberatoria (Disclaimer)

Dichiarazione di non responsabilità: questo articolo non è destinato a fornire consulenza medica, diagnosi o trattamento.
Vitamineral non si assume responsabilità per la scelta degli integratori proposti eventualmente nell’articolo.


image_pdfsalva articolo in PDFimage_printstampa articolo o scarica contenuti